Impedance Pneumography in Assessment of Asthma Control in Preschool Children
IPAAC
1 other identifier
observational
53
1 country
2
Brief Summary
This study evaluates the value of impedance pneumography, used as overnight home recordings during a longitudinal design, in assessing asthma control in preschool children
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2017
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 28, 2017
CompletedFirst Submitted
Initial submission to the registry
December 5, 2017
CompletedFirst Posted
Study publicly available on registry
December 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2020
CompletedFebruary 13, 2020
February 1, 2020
2 years
December 5, 2017
February 12, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Childhood asthma control test (C-ACT)
Questionnaire that measures current asthma control, including 7 questions and a minimum score of 0 and maximum score of 27; score 19 or less indicates that asthma is not controlled.
Weekly up to maximum 6 months or until loss of asthma control/exacerbation
Secondary Outcomes (3)
Time-to-response (TTR)
Minimum of 30 days from initiation of anti-asthmatic medication up to max 6 months
Time-to-loss-of-control (TTLOC)
Minimum of 30 days from initiation of anti-asthmatic medication up to max 6 months
Lung function
Every visit up to maximum 6 months
Eligibility Criteria
Thirty (30) patients who have attended pediatric ward in the study centre(s) due to asthmatic symptoms (wheeze, cough, dyspnea) will be recruited.
You may qualify if:
- Age 4-7 years, both sexes
- Attending pediatric ward in the study centre due to asthmatic symptoms (wheeze, cough and/or dyspnea)
- History and clinical signs allowing diagnosis of doctor diagnosed asthma and the need to start regular anti-asthmatic medication
- Signed informed consent
You may not qualify if:
- Use of inhaled corticosteroid medication 30 days prior to study entry
- Other cardiorespiratory or neurological chronic diseases or states that may affect breathing
- Acute respiratory infection 2 weeks prior to study entry
- Chronic respiratory disorder of prematurity
- Implanted or external active medical devices
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- HUS Skin and Allergy Hospitallead
- Revenio Researchcollaborator
- Mehiläinencollaborator
Study Sites (2)
HUS Skin and Allergy Hospital
Helsinki, 00029, Finland
Mehiläinen Paediatric Allergy Clinic
Helsinki, 00260, Finland
Related Publications (1)
Burman J, Malmberg LP, Remes S, Jartti T, Pelkonen AS, Makela MJ. Impulse oscillometry and free-running tests for diagnosing asthma and monitoring lung function in young children. Ann Allergy Asthma Immunol. 2021 Sep;127(3):326-333. doi: 10.1016/j.anai.2021.03.030. Epub 2021 Apr 2.
PMID: 33819614DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pekka Malmberg, MD, PhD
HUS Skin and Allergy Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of clinical physiology
Study Record Dates
First Submitted
December 5, 2017
First Posted
December 19, 2017
Study Start
November 28, 2017
Primary Completion
November 14, 2019
Study Completion
June 1, 2020
Last Updated
February 13, 2020
Record last verified: 2020-02